Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets
Date
2010Author
Cavusoglu, Kader
Unal, Duri Şehvar
Ozturk, Nuri
Seker, Tuncay
Aslan, Tolga
Duru, Adil Doganay
Saygili, Tahsin
Hoxhaj, Gerta
Hiz, Mahmut Can
Birgul-Iyison, Necla
Ozturk, Mehmet
Koman, Ahmet
Kavak, Ersen
Najafov, Ayaz
Metadata
Show full item recordAbstract
The Wnt signaling pathway is involved in many differentiation events during embryonic development and can lead to tumor formation after aberrant activation of its components. beta-catenin, a cytoplasmic component, plays a major role in the transduction of canonical Wnt signaling. The aim of this study was to identify novel genes that are regulated by active beta-catenin/TCF signaling in hepatocellular carcinoma-derived Huh7 cells with high (transfected) and low beta-catenin/TCF activities. High TCF activity Huh7 cells led to earlier and larger tumor formation when xenografted into nude mice. SAGE (Serial Analysis of Gene Expression), genome-wide microarray and in silico promoter analysis were performed in parallel, to compare gene expression between low and high beta-catenin/TCF activity clones, and also those that had been rescued from the xenograft tumors. SAGE and genome-wide microarray data were compared and contrasted. BRI3 and HSF2 were identified as novel targets of Wnt/beta-catenin signaling after combined analysis and confirming experiments including qRT-PCR, ChIP, luciferase assay and lithium treatment. (C) 2010 Elsevier Inc. All rights reserved.
Collections
- Makale [92796]